These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2710144)

  • 1. Ankle dorsiflexor twitch properties in malignant hyperthermia.
    Quinlan JG; Iaizzo PA; Lambert EH; Gronert GA
    Muscle Nerve; 1989 Feb; 12(2):119-25. PubMed ID: 2710144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-pulse stimulation and dantrolene in malignant hyperthermia.
    Quinlan JG; Wedel DJ; Iaizzo PA
    Muscle Nerve; 1990 Oct; 13(10):904-8. PubMed ID: 2233846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of the tourniquet-twitch test as a diagnostic or screening test for malignant hyperthermia.
    Britt BA; Scott EA; Kleiman A; Jones P; Steward DJ
    Anesth Analg; 1986 Oct; 65(10):1047-50. PubMed ID: 3752552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test].
    Klein W; Spiess-Kiefer C; Küther G; Pongratz D; Lehmann-Horn F
    Anaesthesist; 1987 Dec; 36(12):685-91. PubMed ID: 2830805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In-vitro-effects of cocaine in skeletal muscle specimens of patients susceptible to malignant hyperthermia].
    Weisshorn R; Wappler F; Fiege M; Gerbershagen M; Schulte Am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Mar; 37(3):138-43. PubMed ID: 11889614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of malignant hyperthermia episodes with the Clinical Grading Scale].
    von Richthofen V; Wappler F; Scholz J; Fiege M; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):244-9. PubMed ID: 9617423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant hyperthermia in Austria. II. A comparison of the results of diagnostic test procedures].
    Mauritz W; Hackl W; Sporn P; Graf M; Sluga E; Steinbereithner K
    Anaesthesist; 1988 Jul; 37(7):425-31. PubMed ID: 3414955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Masseter muscle rigidity and malignant hyperthermia susceptibility.
    Rosenberg H; Fletcher JE
    Anesth Analg; 1986 Feb; 65(2):161-4. PubMed ID: 3942303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged electromechanical coupling time intervals in skeletal muscle of pigs susceptible to malignant hyperthermia.
    Nelson TE; Flewellen EH; Arnett DW
    Muscle Nerve; 1983 May; 6(4):263-8. PubMed ID: 6306459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory.
    Weisshorn R; Wappler F; Fiege M; Gerbershagen MU; Kolodzie K; Alberts P; Horn EP; Schulte Am Esch J
    J Clin Anesth; 2004 Aug; 16(5):353-7. PubMed ID: 15374556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
    Sudo RT; Nelson TE
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of the platelet-halothane nucleotide depletion test as a diagnostic or screening test for malignant hyperthermia.
    Britt BA; Scott EA
    Anesth Analg; 1986 Feb; 65(2):171-5. PubMed ID: 3942305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro determination of susceptibility to malignant hyperthermia.
    Iaizzo PA; Lehmann-Horn F
    Muscle Nerve; 1989 Mar; 12(3):184-90. PubMed ID: 2725548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for malignant hyperthermia susceptibility.
    Anderson IL; Rawstron RE; Dunlop DJ
    N Z Med J; 1980 Jun; 91(661):417-9. PubMed ID: 6930029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.
    Schuster F; Metterlein T; Negele S; Kranke P; Muellenbach RM; Schwemmer U; Roewer N; Anetseder M
    Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrodiagnostic tests in the detection of malignant hyperthermia.
    Eng GD; Becker MJ; Muldoon SM
    Muscle Nerve; 1984 Oct; 7(8):618-25. PubMed ID: 6543907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine malignant hyperthermia: cell injury enhances halothane sensitivity of biopsies.
    Gallant EM; Fletcher TF; Goettl VM; Rempel WE
    Muscle Nerve; 1986 Feb; 9(2):174-84. PubMed ID: 3951491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An image analysis study of vastus lateralis muscle fibers in malignant hyperthermia susceptible patients.
    Zukowski F; De Craemer D; Van den Branden C; De Cauwer H; Heytens L; Martin JJ
    Clin Neuropathol; 1998; 17(1):6-11. PubMed ID: 9496533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of disposition for malignant hyperthermia--an updated review based on 1,001 studies].
    Olthoff D; Deutrich C; Meinecke CD
    Anaesthesiol Reanim; 1997; 22(2):32-40. PubMed ID: 9235003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.